Europe Topical Scar Treatment Market Size, Share & Trends Analysis Report By End-use, By Scar Type (Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks), By Product, By Country and Growth Forecast, 2023 - 2030
The Europe Topical Scar Treatment Market would witness market growth of 8.9% CAGR during the forecast period (2023-2030).
The Germany market dominated the Europe Topical Scar Treatment Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $1,776 million by 2030. The UK market is exhibiting a CAGR of 7.9% during (2023 - 2030). Additionally, The France market would experience a CAGR of 9.8% during (2023 - 2030).
Nanotechnology is increasingly being applied to skincare, including scar treatment. Nano-sized particles can increase the penetration of active substances, allowing for improved absorption into the skin and possibly enhancing treatment outcomes. The concept of personalized skincare extends to scar treatment. Some companies are exploring developing products customized to an individual’s skin type, scar severity, and specific needs.
Stretch marks can be treated with topical products designed to improve skin elasticity and lower the appearance of lines and discoloration. These are sometimes prophylactically to minimize scarring after surgery or injury. Early application of these treatments during wound healing can help prevent excessive scar formation. Even scars that have been present for a long time can benefit from topical scar treatments.
As per the UK government’s report named “Future of an aging population,” by 2040, nearly one in seven people is projected to be over 75. By 2037, there are projected to be 1.42 million more households headed by someone aged 85 or over, an increase of 161% over 25 years. The proportion of the working-age population aged between 50 and the state pension age (SPA) will increase from 26% in 2012 to 34% in 2050, an increase of over 5.5 million people. Thus, all these factors will uplift the regional market’s expansion in the coming years.
Based on End-use, the market is segmented into Hospitals, Clinics, and Homecare. Based on Scar Type, the market is segmented into Atrophic Scars, Hypertrophic & Keloid Scars, Contracture Scars, and Stretch Marks. Based on Product, the market is segmented into Creams, Gels, Silicon Sheets, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Smith & Nephew PLC
- Lumenis Be Ltd.
- Merz Pharma GmbH & Co. KGaA
- Sonoma Pharmaceuticals Inc.
- Molnlycke Health Care AB
- Suneva Medical, Inc.
- Perrigo Company PLC
- Cynosure, LLC
- Newmedical Technology Inc.
- Integra LifeSciences Holdings Corporation
By End-use
- Hospitals
- Clinics
- Homecare
- Atrophic Scars
- Hypertrophic & Keloid Scars
- Contracture Scars
- Stretch Marks
- Creams
- Gels
- Silicon Sheets
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Topical Scar Treatment Market, by End-use
- 1.4.2 Europe Topical Scar Treatment Market, by Scar Type
- 1.4.3 Europe Topical Scar Treatment Market, by Product
- 1.4.4 Europe Topical Scar Treatment Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Opportunities
- 3.2.3 Market Restraints
- 3.2.4 Market Challenges
- 3.3 Porter’s Five Forces Analysis
- Chapter 4. Europe Topical Scar Treatment Market by End-use
- 4.1 Europe Hospitals Market by Country
- 4.2 Europe Clinics Market by Country
- 4.3 Europe Homecare Market by Country
- Chapter 5. Europe Topical Scar Treatment Market by Scar Type
- 5.1 Europe Atrophic Scars Market by Country
- 5.2 Europe Hypertrophic & Keloid Scars Market by Country
- 5.3 Europe Contracture Scars Market by Country
- 5.4 Europe Stretch Marks Market by Country
- Chapter 6. Europe Topical Scar Treatment Market by Product
- 6.1 Europe Creams Market by Country
- 6.2 Europe Gels Market by Country
- 6.3 Europe Silicon Sheets Market by Country
- 6.4 Europe Others Market by Country
- Chapter 7. Europe Topical Scar Treatment Market by Country
- 7.1 Germany Topical Scar Treatment Market
- 7.1.1 Germany Topical Scar Treatment Market by End-use
- 7.1.2 Germany Topical Scar Treatment Market by Scar Type
- 7.1.3 Germany Topical Scar Treatment Market by Product
- 7.2 UK Topical Scar Treatment Market
- 7.2.1 UK Topical Scar Treatment Market by End-use
- 7.2.2 UK Topical Scar Treatment Market by Scar Type
- 7.2.3 UK Topical Scar Treatment Market by Product
- 7.3 France Topical Scar Treatment Market
- 7.3.1 France Topical Scar Treatment Market by End-use
- 7.3.2 France Topical Scar Treatment Market by Scar Type
- 7.3.3 France Topical Scar Treatment Market by Product
- 7.4 Russia Topical Scar Treatment Market
- 7.4.1 Russia Topical Scar Treatment Market by End-use
- 7.4.2 Russia Topical Scar Treatment Market by Scar Type
- 7.4.3 Russia Topical Scar Treatment Market by Product
- 7.5 Spain Topical Scar Treatment Market
- 7.5.1 Spain Topical Scar Treatment Market by End-use
- 7.5.2 Spain Topical Scar Treatment Market by Scar Type
- 7.5.3 Spain Topical Scar Treatment Market by Product
- 7.6 Italy Topical Scar Treatment Market
- 7.6.1 Italy Topical Scar Treatment Market by End-use
- 7.6.2 Italy Topical Scar Treatment Market by Scar Type
- 7.6.3 Italy Topical Scar Treatment Market by Product
- 7.7 Rest of Europe Topical Scar Treatment Market
- 7.7.1 Rest of Europe Topical Scar Treatment Market by End-use
- 7.7.2 Rest of Europe Topical Scar Treatment Market by Scar Type
- 7.7.3 Rest of Europe Topical Scar Treatment Market by Product
- Chapter 8. Company Profiles
- 8.1 Smith & Nephew PLC
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional and Segmental Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
- 8.2 Lumenis Be Ltd.
- 8.2.1 Company Overview
- 8.2.2 Recent strategies and developments:
- 8.2.2.1 Partnerships, Collaborations, and Agreements:
- 8.2.2.2 Product Launches and Product Expansions:
- 8.2.3 SWOT Analysis
- 8.3 Merz Pharma GmbH & Co. KGaA
- 8.3.1 Company Overview
- 8.3.2 Recent strategies and developments:
- 8.3.2.1 Partnerships, Collaborations, and Agreements:
- 8.3.3 SWOT Analysis
- 8.4 Sonoma Pharmaceuticals, Inc.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 Recent strategies and developments:
- 8.4.5.1 Product Launches and Product Expansions:
- 8.4.6 SWOT Analysis
- 8.5 Molnlycke Health Care AB
- 8.5.1 Company Overview
- 8.5.2 SWOT Analysis
- 8.6 Suneva Medical, Inc.
- 8.6.1 Company Overview
- 8.6.2 Recent strategies and developments:
- 8.6.2.1 Product Launches and Product Expansions:
- 8.6.3 SWOT Analysis
- 8.7 Perrigo Company PLC
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 SWOT Analysis
- 8.8 Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
- 8.8.1 Company Overview
- 8.8.2 Recent strategies and developments:
- 8.8.2.1 Partnerships, Collaborations, and Agreements:
- 8.8.2.2 Product Launches and Product Expansions:
- 8.8.3 SWOT Analysis
- 8.9 Newmedical Technology Inc.
- 8.9.1 Company Overview
- 8.9.2 SWOT Analysis
- 8.10. Integra LifeSciences Holdings Corporation
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Segmental and Regional Analysis
- 8.10.4 Research & Development Expenses
- 8.10.5 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook